FindTrial
Sign In

Application of MODIS enhanced hepatobiliary cholangiography in predicting the progression of liver cirrhosis

Application of MODIS enhanced hepatobiliary cholangiography in predicting the progression of liver cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041516
Enrollment
Unknown
Registered
2020-12-27
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

The group are divided according to the Child-Pugh score:Nil

Sponsors

Provincial Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing liver MODIS enhanced MRI examination in Shandong provincial hospital from 2012 to 2019.

Exclusion criteria

Exclusion criteria: 1. Patients with diffuse or multinodular liver tumors. 2. Patients with biliary tract involvement. 3. Patients diagnosed with biliary tract diseases. 4. Patients with renal damage. 5. Patients without biochemical data. 6. Patients with image quality problems.

Design outcomes

Primary

MeasureTime frame
hepatic decompensation;hepatic insufficiency;—

Countries

China

Contacts

Public ContactXinya Zhao

Provincial Hospital Affiliated to Shandong First Medical University

zhaoxinya2000@126.com+86 15168887805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026